author_facet Kim, Yang-Gyun
Lowenhaupt, Ky
Oh, Doo-Byoung
Kim, Kyeong Kyu
Rich, Alexander
Kim, Yang-Gyun
Lowenhaupt, Ky
Oh, Doo-Byoung
Kim, Kyeong Kyu
Rich, Alexander
author Kim, Yang-Gyun
Lowenhaupt, Ky
Oh, Doo-Byoung
Kim, Kyeong Kyu
Rich, Alexander
spellingShingle Kim, Yang-Gyun
Lowenhaupt, Ky
Oh, Doo-Byoung
Kim, Kyeong Kyu
Rich, Alexander
Proceedings of the National Academy of Sciences
Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
Multidisciplinary
author_sort kim, yang-gyun
spelling Kim, Yang-Gyun Lowenhaupt, Ky Oh, Doo-Byoung Kim, Kyeong Kyu Rich, Alexander 0027-8424 1091-6490 Proceedings of the National Academy of Sciences Multidisciplinary http://dx.doi.org/10.1073/pnas.0308260100 <jats:p> The E3L gene product found in all poxviruses is required for the lethality of mice in vaccinia virus infection. Both the C-terminal region, consisting of a double-stranded RNA-binding motif, and the N-terminal region (vZ <jats:sub>E3L</jats:sub> ), which is similar to the Zα family of Z-DNA-binding proteins, are required for infection. It has recently been demonstrated that the function of the N-terminal domain depends on its ability to bind Z-DNA; Z-DNA-binding domains from unrelated mammalian proteins fully complement an N-terminal deletion of E3L. Mutations that decrease affinity for Z-DNA have similar effects in decreasing pathogenicity. Compounds that block the Z-DNA-binding activity of E3L may also limit infection by the poxvirus. Here we show both an <jats:italic>in vitro</jats:italic> and an <jats:italic>in vivo</jats:italic> assay with the potential to be used in screening for such compounds. Using a conformation-specific yeast one-hybrid assay, we compared the results for Z-DNA binding of vZ <jats:sub>E3L</jats:sub> with those for human Zβ <jats:sub>ADAR1</jats:sub> , a peptide that has similarity to the Zα motif but does not bind Z-DNA, and with a mutant of hZβ <jats:sub>ADAR1</jats:sub> , which binds Z-DNA. The results suggest that this system can be used for high-throughput screening. </jats:p> Evidence that vaccinia virulence factor E3L binds to Z-DNA <i>in vivo</i> : Implications for development of a therapy for poxvirus infection Proceedings of the National Academy of Sciences
doi_str_mv 10.1073/pnas.0308260100
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjAzMDgyNjAxMDA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjAzMDgyNjAxMDA
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Proceedings of the National Academy of Sciences, 2004
imprint_str_mv Proceedings of the National Academy of Sciences, 2004
issn 0027-8424
1091-6490
issn_str_mv 0027-8424
1091-6490
language English
mega_collection Proceedings of the National Academy of Sciences (CrossRef)
match_str kim2004evidencethatvacciniavirulencefactore3lbindstozdnainvivoimplicationsfordevelopmentofatherapyforpoxvirusinfection
publishDateSort 2004
publisher Proceedings of the National Academy of Sciences
recordtype ai
record_format ai
series Proceedings of the National Academy of Sciences
source_id 49
title Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_unstemmed Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_full Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_fullStr Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_full_unstemmed Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_short Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_sort evidence that vaccinia virulence factor e3l binds to z-dna <i>in vivo</i> : implications for development of a therapy for poxvirus infection
topic Multidisciplinary
url http://dx.doi.org/10.1073/pnas.0308260100
publishDate 2004
physical 1514-1518
description <jats:p> The E3L gene product found in all poxviruses is required for the lethality of mice in vaccinia virus infection. Both the C-terminal region, consisting of a double-stranded RNA-binding motif, and the N-terminal region (vZ <jats:sub>E3L</jats:sub> ), which is similar to the Zα family of Z-DNA-binding proteins, are required for infection. It has recently been demonstrated that the function of the N-terminal domain depends on its ability to bind Z-DNA; Z-DNA-binding domains from unrelated mammalian proteins fully complement an N-terminal deletion of E3L. Mutations that decrease affinity for Z-DNA have similar effects in decreasing pathogenicity. Compounds that block the Z-DNA-binding activity of E3L may also limit infection by the poxvirus. Here we show both an <jats:italic>in vitro</jats:italic> and an <jats:italic>in vivo</jats:italic> assay with the potential to be used in screening for such compounds. Using a conformation-specific yeast one-hybrid assay, we compared the results for Z-DNA binding of vZ <jats:sub>E3L</jats:sub> with those for human Zβ <jats:sub>ADAR1</jats:sub> , a peptide that has similarity to the Zα motif but does not bind Z-DNA, and with a mutant of hZβ <jats:sub>ADAR1</jats:sub> , which binds Z-DNA. The results suggest that this system can be used for high-throughput screening. </jats:p>
container_issue 6
container_start_page 1514
container_title Proceedings of the National Academy of Sciences
container_volume 101
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792337532774514690
geogr_code not assigned
last_indexed 2024-03-01T15:17:50.152Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Evidence+that+vaccinia+virulence+factor+E3L+binds+to+Z-DNA++++++++++++in+vivo++++++++++++%3A+Implications+for+development+of+a+therapy+for+poxvirus+infection&rft.date=2004-02-10&genre=article&issn=1091-6490&volume=101&issue=6&spage=1514&epage=1518&pages=1514-1518&jtitle=Proceedings+of+the+National+Academy+of+Sciences&atitle=Evidence+that+vaccinia+virulence+factor+E3L+binds+to+Z-DNA%0A++++++++++++%3Ci%3Ein+vivo%3C%2Fi%3E%0A++++++++++++%3A+Implications+for+development+of+a+therapy+for+poxvirus+infection&aulast=Rich&aufirst=Alexander&rft_id=info%3Adoi%2F10.1073%2Fpnas.0308260100&rft.language%5B0%5D=eng
SOLR
_version_ 1792337532774514690
author Kim, Yang-Gyun, Lowenhaupt, Ky, Oh, Doo-Byoung, Kim, Kyeong Kyu, Rich, Alexander
author_facet Kim, Yang-Gyun, Lowenhaupt, Ky, Oh, Doo-Byoung, Kim, Kyeong Kyu, Rich, Alexander, Kim, Yang-Gyun, Lowenhaupt, Ky, Oh, Doo-Byoung, Kim, Kyeong Kyu, Rich, Alexander
author_sort kim, yang-gyun
container_issue 6
container_start_page 1514
container_title Proceedings of the National Academy of Sciences
container_volume 101
description <jats:p> The E3L gene product found in all poxviruses is required for the lethality of mice in vaccinia virus infection. Both the C-terminal region, consisting of a double-stranded RNA-binding motif, and the N-terminal region (vZ <jats:sub>E3L</jats:sub> ), which is similar to the Zα family of Z-DNA-binding proteins, are required for infection. It has recently been demonstrated that the function of the N-terminal domain depends on its ability to bind Z-DNA; Z-DNA-binding domains from unrelated mammalian proteins fully complement an N-terminal deletion of E3L. Mutations that decrease affinity for Z-DNA have similar effects in decreasing pathogenicity. Compounds that block the Z-DNA-binding activity of E3L may also limit infection by the poxvirus. Here we show both an <jats:italic>in vitro</jats:italic> and an <jats:italic>in vivo</jats:italic> assay with the potential to be used in screening for such compounds. Using a conformation-specific yeast one-hybrid assay, we compared the results for Z-DNA binding of vZ <jats:sub>E3L</jats:sub> with those for human Zβ <jats:sub>ADAR1</jats:sub> , a peptide that has similarity to the Zα motif but does not bind Z-DNA, and with a mutant of hZβ <jats:sub>ADAR1</jats:sub> , which binds Z-DNA. The results suggest that this system can be used for high-throughput screening. </jats:p>
doi_str_mv 10.1073/pnas.0308260100
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjAzMDgyNjAxMDA
imprint Proceedings of the National Academy of Sciences, 2004
imprint_str_mv Proceedings of the National Academy of Sciences, 2004
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0027-8424, 1091-6490
issn_str_mv 0027-8424, 1091-6490
language English
last_indexed 2024-03-01T15:17:50.152Z
match_str kim2004evidencethatvacciniavirulencefactore3lbindstozdnainvivoimplicationsfordevelopmentofatherapyforpoxvirusinfection
mega_collection Proceedings of the National Academy of Sciences (CrossRef)
physical 1514-1518
publishDate 2004
publishDateSort 2004
publisher Proceedings of the National Academy of Sciences
record_format ai
recordtype ai
series Proceedings of the National Academy of Sciences
source_id 49
spelling Kim, Yang-Gyun Lowenhaupt, Ky Oh, Doo-Byoung Kim, Kyeong Kyu Rich, Alexander 0027-8424 1091-6490 Proceedings of the National Academy of Sciences Multidisciplinary http://dx.doi.org/10.1073/pnas.0308260100 <jats:p> The E3L gene product found in all poxviruses is required for the lethality of mice in vaccinia virus infection. Both the C-terminal region, consisting of a double-stranded RNA-binding motif, and the N-terminal region (vZ <jats:sub>E3L</jats:sub> ), which is similar to the Zα family of Z-DNA-binding proteins, are required for infection. It has recently been demonstrated that the function of the N-terminal domain depends on its ability to bind Z-DNA; Z-DNA-binding domains from unrelated mammalian proteins fully complement an N-terminal deletion of E3L. Mutations that decrease affinity for Z-DNA have similar effects in decreasing pathogenicity. Compounds that block the Z-DNA-binding activity of E3L may also limit infection by the poxvirus. Here we show both an <jats:italic>in vitro</jats:italic> and an <jats:italic>in vivo</jats:italic> assay with the potential to be used in screening for such compounds. Using a conformation-specific yeast one-hybrid assay, we compared the results for Z-DNA binding of vZ <jats:sub>E3L</jats:sub> with those for human Zβ <jats:sub>ADAR1</jats:sub> , a peptide that has similarity to the Zα motif but does not bind Z-DNA, and with a mutant of hZβ <jats:sub>ADAR1</jats:sub> , which binds Z-DNA. The results suggest that this system can be used for high-throughput screening. </jats:p> Evidence that vaccinia virulence factor E3L binds to Z-DNA <i>in vivo</i> : Implications for development of a therapy for poxvirus infection Proceedings of the National Academy of Sciences
spellingShingle Kim, Yang-Gyun, Lowenhaupt, Ky, Oh, Doo-Byoung, Kim, Kyeong Kyu, Rich, Alexander, Proceedings of the National Academy of Sciences, Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection, Multidisciplinary
title Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_full Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_fullStr Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_full_unstemmed Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_short Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
title_sort evidence that vaccinia virulence factor e3l binds to z-dna <i>in vivo</i> : implications for development of a therapy for poxvirus infection
title_unstemmed Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo : Implications for development of a therapy for poxvirus infection
topic Multidisciplinary
url http://dx.doi.org/10.1073/pnas.0308260100